Cong‐Yi Wang
- Nephrology top 1%
- Immunology top 1%
- Immune Cell Function and Interaction 31
- T-cell and B-cell Immunology 15
- Clinical Biochemistry top 0.5%
-
- Hormonal Regulation and Hypertension 11
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 10
-
- Diabetes and associated disorders 23
-
- Pancreatic function and diabetes 22
-
- Ubiquitin and proteasome pathways 18
-
- Asthma and respiratory diseases 10
- Co-authors
- Jin‐Xiong SheZheng DongPing YangQilin YuWeining XiongMan JiangFeili GongYi Wang
- Journals
- American Journal of Physiology-Renal Physiology (7 papers)Frontiers in Immunology (6 papers)Cell Death and Disease (5 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Cong‐Yi Wang
227 papers receiving 8.0k citations
Peers
Comparison fields: 5 of 166
- Nephrology 580
- Immunology 1.6k
- Clinical Biochemistry 444
- Endocrinology, Diabetes and Metabolism 891
- Biochemistry 349
Countries citing papers authored by Cong‐Yi Wang
This map shows the geographic impact of Cong‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong‐Yi Wang more than expected).
Fields of papers citing papers by Cong‐Yi Wang
This network shows the impact of papers produced by Cong‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong‐Yi Wang. The network helps show where Cong‐Yi Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cong‐Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 86 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 26 | |
| 12 | 2020 | 33 | |
| 13 | 2018 | 15 | |
| 14 | 2017 | 47 | |
| 15 | IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation. | 2015 | 7 |
| 16 | Clinical and genetic characteristics for the Urofacial Syndrome (UFS). | 2014 | 8 |
| 17 | 2012 | 50 | |
| 18 | 2010 | 126 | |
| 19 | 2008 | 128 | |
| 20 | Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. | 2008 | 208 |
About Cong‐Yi Wang
Cong‐Yi Wang is a scholar working on Immunology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 231 papers that have together received 8.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (31 papers), Diabetes and associated disorders (23 papers), Pancreatic function and diabetes (22 papers), Ubiquitin and proteasome pathways (18 papers), T-cell and B-cell Immunology (15 papers), Hormonal Regulation and Hypertension (11 papers), Asthma and respiratory diseases (10 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). The work is most often cited by research in Nephrology (580 citations), Immunology (1.6k citations) and Clinical Biochemistry (444 citations). Cong‐Yi Wang has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jin‐Xiong She, Zheng Dong, Ping Yang, Qilin Yu, Weining Xiong, Ping Yang, Man Jiang, Feili Gong, Yi Wang and Weikuan Gu. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Frontiers in Immunology, Cell Death and Disease, Proceedings of the National Academy of Sciences and The American Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.